Cargando…
IL3RA-Targeting Antibody–Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic Malignancies
SIMPLE SUMMARY: IL3RA (alpha subunit of the interleukin 3 receptor) is a cell membrane protein frequently expressed in acute myeloid leukemia (AML) and Hodgkin lymphoma; therefore, it is a promising therapeutic target for cancer treatment. Here, we introduce BAY-943, a novel IL3RA-targeting antibody...
Autores principales: | Kirchhoff, Dennis, Stelte-Ludwig, Beatrix, Lerchen, Hans-Georg, Wengner, Antje Margret, von Ahsen, Oliver, Buchmann, Pascale, Märsch, Stephan, Mahlert, Christoph, Greven, Simone, Dietz, Lisa, Erkelenz, Michael, Zierz, Ruprecht, Johanssen, Sandra, Mumberg, Dominik, Sommer, Anette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709048/ https://www.ncbi.nlm.nih.gov/pubmed/33233768 http://dx.doi.org/10.3390/cancers12113464 |
Ejemplares similares
-
A Novel NAMPT Inhibitor-Based Antibody–Drug
Conjugate Payload Class for Cancer Therapy
por: Böhnke, Niels, et al.
Publicado: (2022) -
A Small Molecule–Drug Conjugate (SMDC) Consisting of a Modified Camptothecin Payload Linked to an α(V)ß(3) Binder for the Treatment of Multiple Cancer Types
por: Lerchen, Hans-Georg, et al.
Publicado: (2022) -
Discovery of VIP236, an αvβ3-Targeted Small-Molecule–Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors
por: Lerchen, Hans-Georg, et al.
Publicado: (2023) -
Antibody–drug conjugates harboring a kinesin spindle protein inhibitor with immunostimulatory properties
por: Sommer, Anette, et al.
Publicado: (2022) -
943. Epidemiology of Actinomycosis in a Tertiary Care Cancer Center
por: El-Atoum, Mohammad, et al.
Publicado: (2021)